Loading in 2 Seconds...
Loading in 2 Seconds...
The implantable drug delivery devices market is expected to exceed more than US$ 27 billion by 2021; Growing at a CAGR of more than 8.6% in the given forecast period.
Implantable Drug Delivery Devices Market is Expected to Reach US$ 27 Billion by2021
Market Research Engine has published a new report titled as “Implantable Drug Delivery Devices Market by Applications, by Product Types and by Technology - Global Market Analysis and Forecast 2016 -2021”
The implantable drug delivery devices market is expected to exceed more than US$ 27 billion by 2021; Growing at a CAGR of more than 8.6% in the given forecastperiod.
Implantable devices having many functions such as it vascular stents preserve flow of blood. The electro-stimulation devices control heart block spurious in the brain. Implantable drug delivery devices permit site specific drug management where that drug requires more. There has been rising union between drug therapies and implantable devices such as devices that carry drugs as primeaction.
The major driving factors of implantable drug delivery devices market are as follows:
Driving factors for the global contraceptive drug delivery implants market NGO and government initiatives to support contraceptive goods Increasing frequency of unwantedpregnancies
Driving factors for the global intraocular drug delivery implantsmarket
Increasing patient group for diabetic retinopathy and diabetes Growing aging populationglobally
Driving factors for the global implantable drug infusion pumps market High predominance of chronic pain causingdisorders
Increasing frequency of colorectal cancer globally Driving factors for the global brachytherapy seedsmarket
Appearance of new disease appliances Growing prevalence of prostate cancerglobally
Driving factors for the global coronary stents Increasing many interventional cardiologists Rising frequency of cardiovasculardiseases
Browse Full Report: https://www.marketresearchengine.com/reportdetails/implantable- drug-delivery-devices-market
The restraining factors of implantable drug delivery devices market are asfollows:
Strict CE and FDA approvalnorms.
The introduction of internal product substitutes, lawsuits and productrecalls.
The implantable drug delivery devices market is segmented on the lines of its product type, technology, application and regional. Based on product type segmentation it covers implantable drug infusion pumps, implantable brachytherapy seeds, implantable intraocular drug delivery devices, implantable contraceptive drug delivery devices, implantable bio absorbable stents and implantable coronary drug eluting stents. Under technology segmentation the implantable drug delivery devices market contains non biodegradable implantable drug delivery device technology and biodegradable implantable drug delivery device technology. The implantable drug delivery devices market is segmented on the lines of its application like oncology, birth control/ contraception, cardiovascular, ophthalmology and others such as chronic pain causing diseases and diabetes. The implantable drug delivery devices markets geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCCcountries.
An overview of the global market for implantable drug delivery devices and related technologies.
Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through2021.
Identifications of new market opportunities and targeted promotional plans for implantable drug deliverydevices.
Discussion of research and development, and the demand for new products and new applications.
Comprehensive company profiles of major players in theindustry.
The scope of the report includes a detailed study of global and regional markets for Implantable drug delivery devices with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market, current market trends and situations. Key players profiled in the report include Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories and Bausch and Lomb Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
Sample Report: https://www.marketresearchengine.com/reportdetails/implantable-drug- delivery-devices-market
The Implantable drug delivery devices Markethas been segmented asbelow:
By Product TypeAnalysis
Implantable drug infusion pumps Implantable brachytherapy seeds Implantable intraocular drug deliverydevices
Implantable contraceptive drug delivery devices Implantable bio absorbablestents
Implantable coronary drug elutingstents
By Technology Analysis
Non biodegradable implantable drug delivery device technology Biodegradable implantable drug delivery devicetechnology
Birth control/ contraception Cardiovascular Ophthalmology
Other (chronic pain causing diseases,diabetes)
Rest of theWorld
Chapter 2 Executive Summary Chapter 3 MarketOverview
Chapter 4 Implantable Drug Delivery Devices Market, By Product Types Chapter 5 Global Implantable Drug Delivery Devices Market, By Technology Chapter 6 Global Implantable Drug Delivery Devices Market, By Applications Chapter 7 Implantable Drug Delivery Devices Market ByGeography
Company Name: Market ResearchEngine
Contact Person: JohnBay